CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances<i>In vivo</i>Persistence and Antitumor Efficacy of Adoptively Transferred T Cells

Claudia Kowolik, Laurence J.N. Cooper, Stephen J. Forman et al.|Cancer Research|2006

Cited by 487